Lv5
1585 积分 2021-06-28 加入
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
1个月前
已完结
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
1个月前
已完结
Identifying key randomised clinical trials that could transform clinical care and public health
1个月前
已关闭
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
1个月前
已完结
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
1个月前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
3个月前
已完结
Claudin 18.2 as a novel therapeutic target
3个月前
已完结
Early diagnosis of early gastric cancer
3个月前
已完结
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma
3个月前
已完结
Using the National Cancer Database for Outcomes Research
4个月前
已完结
皖公网安备34019202002308
